Blood Test Co. Says Rival Falsely Advertised FDA Status
Kurin Inc. accused a competitor in the market for reducing false positives in blood tests of inaccurately advertising its device as if it were approved by the U.S. Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article